163 results on '"Yang, Hongqiu"'
Search Results
2. Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
3. A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia
4. Design and pilot test of an implicit bias mitigation curriculum for clinicians
5. MP78-19 CHARACTERIZING PAIN LOCATION AND INTENSITY FOLLOWING URETEROSCOPY FOR STONES—RESULTS FROM THE USDRN STUDY TO ENHANCE UNDERSTANDING OF STENT-ASSOCIATED SYMPTOMS (STENTS)
6. Examining the relationship between clinician communication and patient participatory behaviors in cardiology encounters
7. Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data
8. Mobile Application–Based Communication Facilitation Platform for Family Members of Critically Ill Patients
9. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
10. Effect of a Coaching Intervention to Improve Cardiologist Communication
11. PD34-03 PRE-OPERATIVE CENTRAL SENSITIZATION AND HYPERSENSITIVITY TO PAIN IS ASSOCIATED WITH URETERAL STENT PAIN: FINDINGS FROM THE URINARY STONE DISEASE RESEARCH NETWORK (USDRN)
12. PD34-04 PREDICTIVE MODELS FOR SEVERE PAIN AND URINARY SYMPTOMS AFTER URETEROSCOPY WITH URETERAL STENT PLACEMENT FROM THE USDRN STENTS STUDY
13. The Distributive Norm of Monetary Support to Older Parents: A Look at a Township in China
14. Risk Factors for Increased Stent-Associated Symptoms Following Ureteroscopy for Urinary Stones: Results from STENTS
15. Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity
16. Characteristics Associated with Burnout among Cardiologists in an Academic Medical Setting: Baseline Survey Results from a Communication Coaching RCT
17. Abstract 20846: The Impact of a Palliative Care Intervention on Polypharmacy in Advanced HF: Results From Pal-HF
18. SOX9 in Keratinocytes Regulates Claudin 2 Transcription during Skin Aging
19. Highly Specialized Carbohydrate Metabolism Capability in Bifidobacterium Strains Associated with Intestinal Barrier Maturation in Early Preterm Infants
20. LBA02-08 RISK FACTORS FOR INCREASED STENT-ASSOCIATED SYMPTOMS FOLLOWING URETEROSCOPY FOR URINARY STONES: RESULTS FROM THE URINARY STONE DISEASE RESEARCH NETWORK (USDRN) STENTS STUDY
21. PD50-07 DEFINING STONE PASSAGE IN A CLINICAL TRIAL: ADJUDICATION IN THE PREVENTION OF URINARY STONES WITH HYDRATION (PUSH) STUDY
22. Additional file 2 of Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data
23. Additional file 1 of Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data
24. Additional file 7 of Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data
25. Chlamydia caviae infection alters abundance but not composition of the guinea pig vaginal microbiota
26. Communication Coaching in Cardiology (CCC): A study protocol and methodological challenges and solutions of a randomized controlled trial in outpatient cardiology clinics
27. The Patient's Point of View: Characterizing Patient-Level Factors Associated with Perceptions of Health Care
28. Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
29. Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome
30. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
31. Improving racial disparities in unmet palliative care needs among intensive care unit family members with a needs-targeted app intervention: The ICUconnect randomized clinical trial
32. Polygoni Multiflori Radix Preparat Delays Skin Aging by Inducing Mitophagy
33. Vascular Endothelial Tissue Factor Pathway Inhibitor Kinetics in Culture Following Exposure to DX-9065a—A Selective and Direct Factor Xa Inhibitor
34. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
35. Vascular Endothelial Tissue Factor Pathway Inhibitor Kinetics in Culture Following Exposure to DX-9065a-A Selective and Direct Factor Xa Inhibitor
36. A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes
37. African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial
38. Ultrahigh-Throughput Multiplexing and Sequencing of >500-Base-Pair Amplicon Regions on the Illumina HiSeq 2500 Platform
39. Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants
40. Role of autophagy in skin photoaging: A narrative review
41. Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial
42. Ultra-high throughput multiplexing and sequencing of >500 bp amplicon regions on the Illumina HiSeq 2500 platform
43. Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
44. Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
45. Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction
46. Palliative Care in Heart Failure
47. Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity
48. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation : a secondary analysis of a randomised controlled trial
49. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome
50. EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO AGE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.